Distribution and inhibition of dihydrouracil dehydrogenase activities in human tissues using 5-fluorouracil as a substrate.
about
Crystal structure of dihydropyrimidine dehydrogenase, a major determinant of the pharmacokinetics of the anti-cancer drug 5-fluorouracilCharacterization of dihydropyrimidine dehydrogenase in human colorectal tumoursEvaluations of biomarkers associated with 5-FU sensitivity for non-small-cell lung cancer patients postoperatively treated with UFTProfound variation in dihydropyrimidine dehydrogenase activity in human blood cells: major implications for the detection of partly deficient patients.Reduced 5-FU clearance in a patient with low DPD activity due to heterozygosity for a mutant allele of the DPYD gene.Clinical significance of the thymidylate synthase, dihydropyrimidine dehydrogenase, and thymidine phosphorylase mRNA expressions in hepatocellular carcinoma patients receiving 5-fluorouracil-based transarterial chemoembolization treatmentSomatic copy number changes in DPYD are associated with lower risk of recurrence in triple-negative breast cancers.Physiologically based pharmacokinetic modelling of the three-step metabolism of pyrimidine using C-uracil as an in vivo probe.CPT-11 alters the circadian rhythm of dihydropyrimidine dehydrogenase mRNA in mouse liver.Clinical significance of dihydropyrimidine dehydrogenase in adjuvant 5-fluorouracil liver perfusion chemotherapy for pancreatic cancer.Inhibition of catabolic pathway of 5-fluorouracil by 3-cyano-2,6-dihydroxypyridine in human lung cancer tissues.Oral administration of BOF-A2 to rats with lung transplanted tumors results in increased 5-fluorouracil levels.
P2860
Q27629628-369A4B98-C5BF-4CB6-A00C-47F00BB88B0EQ36295138-D7AE1271-8EA6-4DD1-9DFE-2000FF882A91Q36612324-B7E63F35-A43A-44B2-8076-51D2AF1A5344Q36618173-7312C51D-0A2F-4584-9E06-C1741551EF02Q36623852-57202F36-4D62-4871-8A1B-DB52FD14EDF5Q36992444-75563337-3884-48FD-B0C3-1A6F17492018Q37279312-0A2B8C0A-6038-459D-AE6F-3F004DB1631EQ42283992-3FEA9E18-926F-4042-85D0-A4B3DC4D3DD8Q43619712-3DEB4018-64EC-4DDD-92DF-F56DD92704C8Q45113388-71E1E75A-D58F-4C0E-8CEE-8C8B37B9E391Q55244501-A55696C7-2582-46C7-8BB3-A14C20255CBEQ55296985-007895BB-5454-4237-974F-A4FD2752574A
P2860
Distribution and inhibition of dihydrouracil dehydrogenase activities in human tissues using 5-fluorouracil as a substrate.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Distribution and inhibition of ...... 5-fluorouracil as a substrate.
@en
Distribution and inhibition of ...... 5-fluorouracil as a substrate.
@nl
type
label
Distribution and inhibition of ...... 5-fluorouracil as a substrate.
@en
Distribution and inhibition of ...... 5-fluorouracil as a substrate.
@nl
prefLabel
Distribution and inhibition of ...... 5-fluorouracil as a substrate.
@en
Distribution and inhibition of ...... 5-fluorouracil as a substrate.
@nl
P2093
P1433
P1476
Distribution and inhibition of ...... 5-fluorouracil as a substrate.
@en
P2093
P304
P407
P577
1986-07-01T00:00:00Z